Cenra Inc. (TWSE: 3716)
Health Care · Pharmaceuticals · TW
NT$34.15
+0.74% today · +2.6% 1Y
Cenra Inc. (TWSE: 3716) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $155.60M and employs 1,902 people.
Over the last twelve months the share price has gained 2.6%, trading between 31.55 and 37.65.
Tweenvest scores Cenra Inc. across four factors: quality 71/100, value 66/100, growth 12/100, dividend 82/100. Its strongest factor is dividend.
3716 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $155.60M
- Revenue (TTM)
- $265.17M
- P/E
- 8.38
- EPS
- 4.07
- Dividend yield
- 2.94%
- Beta (5Y)
- 0.24
- 52-week high
- NT$37.65
- 52-week low
- NT$31.55
- Avg volume (3M)
- —
- Shares outstanding
- 145.69M
- Employees
- 1,902
- Next earnings
- —
About Cenra Inc.
China Chemical & Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals. The company provides sexual function supplements; cardiovascular drugs, anti-lipidemia drugs, and peripheral circulation impediment relieving agents; diabetes treatment drugs, adrenocortico steroids, and weight control drugs; and anti-infection drugs, such as antibiotics, antifungal drugs, and anti-viral drugs. It also offers nutritional supplements comprising vitamins, liver toning agents, and electrolyte and calorie preparations; antipyretic, analgesic, and anti-inflammatory medicines; digestive drugs, intestinal improvement agents, and antispasmodics; cough suppressants, antihistamines, and asthma treatment agents; BPH drugs for the urinary system; hypnotic, mental stability, and antidepressant drugs; hematology/oncology drugs; and other general preparations. In addition, the company provides over the counter drugs such as vitamins, external skin care products, cold and cough medicines, anti-inflammatory analgesics, and gastrointestinal drugs; and antibacterial and disinfection medicines. Further, it manufactures animal health products, including drugs for pigs and cattle, companion animal products, poultry drugs, and feed supplements; and offers contract manufacturing services. The company was founded in 1952 and is headquartered in Taipei, Taiwan.
- ISIN
- TW0003716007
- Founded
- 2024
- Listed since
- Jan 4, 2000
- Exchange
- Taiwan Stock Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Hyundai Pharmaceutical Co., Ltd.KOSE: A004310 | $159.76M | ₩7,760.00 | -6.95% |
| Zhaoke Ophthalmology LimitedSEHK: 6622 | $158.23M | HK$2.27 | -8.65% |
| TerrAscend Corp.TSX: TSND | $157.10M | CA$0.73 | -3.33% |
| AGP LimitedKASE: AGP | $156.49M | PKRs155.48 | +2.42% |
| Societe de Promotion Pharmaceutique du Maghreb S.A.CBSE: PRO | $155.42M | MAD— | — |
| Anlon Healthcare LimitedNSEI: AHCL | $154.38M | Rs28.11 | -14.46% |
| Jagsonpal Pharmaceuticals LimitedNSEI: JAGSNPHARM | $153.68M | Rs225.60 | -2.65% |
| Fermenta Biotech LimitedBSE: 506414 | $153.31M | Rs517.50 | -6.14% |
Figures last refreshed Oct 11, 2026.